Reason for request
Inclusion
Clinical Benefit
| Moderate |
Moderate AB pending re-assessment of oral antihistamines. |
Clinical Added Value
| no clinical added value |
No improvement in actual benefit (IAB V) compared with other oral H1 antihistamines available in oral form. |
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
Xxahj9jSKRuBkCfY
Listen
